Corticosteroids for viral central nervous system infections

Area of Science:

• Neurology
• Infectious Diseases
• Pharmacology

Background:

• Viruses frequently cause central nervous system (CNS) infections.
• Antiviral treatments may be limited or ineffective, leading to the use of corticosteroids.
• Corticosteroids have anti-inflammatory and immunosuppressive properties.

Purpose of the Study:

• To review the rationale and clinical experience of using corticosteroids as an adjunctive therapy for viral CNS infections.
• To evaluate the efficacy and safety of corticosteroids in managing viral meningitis, myelitis, and encephalitis.

Main Methods:

• Review of existing literature, including population-based studies, observational data, and randomized clinical trials.
• Analysis of the effects of corticosteroids on viral CNS infections based on current evidence.

Main Results:

• Empiric dexamethasone for viral meningitis showed no significant improvement or adverse effects.
• Standard empiric treatment for myelitis involves methylprednisolone, with no strong data to alter this approach for viral myelitis.
• Adjunctive corticosteroids in viral encephalitis have not demonstrated substantial benefits in observational data or clinical trials.
• Observed risks associated with corticosteroid use in these conditions were generally low.

Conclusions:

• Routine use of corticosteroids is not supported for viral CNS infections, with the exception of myelitis.
• Further large-scale, multidisciplinary trials are necessary to establish evidence-based treatment guidelines for conditions like encephalitis.